FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016219982> ?p ?o ?g. }

• W2016219982 endingPage "40" @default.
• W2016219982 startingPage "35" @default.
• W2016219982 abstract "Bisphosphonates are expected to be efficacious to prevent the growth of metastatic cancer in bone tissue. Bone metastases often occur in patients with various cancers, such as breast, lung and prostate cancer. Bcl-2 is a potent antiapoptotic protein and its expression is known to be closely related to its function. In this study, to investigate the effect of bisphosphonates on cancer cells, we focused on bcl-2 expression in bisphosphonate-treated prostate cancer cells. First, we observed that bcl-2 mRNA expression in PC-3 was significantly inhibited to 12% of the control level by treatment with 100 microM pamidronate for 12h. Inhibition was seen in cells treated with nitrogen-containing bisphosphonates, which have the ability to inhibit isoprenoid biosynthesis via the mevalonate pathway, but not in non-nitrogen-containing etidronate. Simultaneous treatment with geranylgeraniol, an intermediate of the mevalonate pathway, significantly blocked inhibition by pamidronate, and treatment with geranylgeranyl transferase inhibitor GGTI-286 also suppressed bcl-2 mRNA expression. Furthermore, pamidronate inhibited the translocation of Rap1 protein to the membrane fraction, suggesting that a change in posttranslational modification of Rap1 occurred in treated cells. Finally, knockdown of Rap1 by siRNA resulted in the inhibition of bcl-2 expression. These results strongly indicate that bcl-2 reduction in bisphosphonate-treated PC-3 cells is dependent on inhibition of the mevalonate pathway. The inhibitory effect of bisphosphonates on bcl-2 expression shown in prostate cancer cell line should be tested in animal experiments and clinical studies." @default.
• W2016219982 created "2016-06-24" @default.
• W2016219982 creator A5021941218 @default.
• W2016219982 creator A5035309136 @default.
• W2016219982 creator A5072050367 @default.
• W2016219982 creator A5072962309 @default.
• W2016219982 date "2010-09-01" @default.
• W2016219982 modified "2023-09-27" @default.
• W2016219982 title "Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells" @default.
• W2016219982 cites W1862785984 @default.
• W2016219982 cites W1929670121 @default.
• W2016219982 cites W1965259410 @default.
• W2016219982 cites W1967320410 @default.
• W2016219982 cites W1975290731 @default.
• W2016219982 cites W1982560959 @default.
• W2016219982 cites W1990802782 @default.
• W2016219982 cites W1994414479 @default.
• W2016219982 cites W2001748188 @default.
• W2016219982 cites W2019241142 @default.
• W2016219982 cites W2024266959 @default.
• W2016219982 cites W2029620076 @default.
• W2016219982 cites W2030190513 @default.
• W2016219982 cites W2039953525 @default.
• W2016219982 cites W2041402315 @default.
• W2016219982 cites W2041868422 @default.
• W2016219982 cites W2045747724 @default.
• W2016219982 cites W2049046201 @default.
• W2016219982 cites W2065869497 @default.
• W2016219982 cites W2071657628 @default.
• W2016219982 cites W2076262158 @default.
• W2016219982 cites W2076295899 @default.
• W2016219982 cites W2085197560 @default.
• W2016219982 cites W2102579900 @default.
• W2016219982 cites W2110435961 @default.
• W2016219982 cites W2113503879 @default.
• W2016219982 cites W2115268409 @default.
• W2016219982 cites W2131802504 @default.
• W2016219982 cites W2135945275 @default.
• W2016219982 cites W2139314315 @default.
• W2016219982 cites W2148096512 @default.
• W2016219982 cites W2152662617 @default.
• W2016219982 doi "https://doi.org/10.1016/j.ejphar.2010.05.010" @default.
• W2016219982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20519142" @default.
• W2016219982 hasPublicationYear "2010" @default.
• W2016219982 type Work @default.
• W2016219982 sameAs 2016219982 @default.
• W2016219982 citedByCount "14" @default.
• W2016219982 countsByYear W20162199822012 @default.
• W2016219982 countsByYear W20162199822014 @default.
• W2016219982 countsByYear W20162199822015 @default.
• W2016219982 countsByYear W20162199822016 @default.
• W2016219982 countsByYear W20162199822019 @default.
• W2016219982 countsByYear W20162199822020 @default.
• W2016219982 countsByYear W20162199822021 @default.
• W2016219982 countsByYear W20162199822023 @default.
• W2016219982 crossrefType "journal-article" @default.
• W2016219982 hasAuthorship W2016219982A5021941218 @default.
• W2016219982 hasAuthorship W2016219982A5035309136 @default.
• W2016219982 hasAuthorship W2016219982A5072050367 @default.
• W2016219982 hasAuthorship W2016219982A5072962309 @default.
• W2016219982 hasConcept C121608353 @default.
• W2016219982 hasConcept C126322002 @default.
• W2016219982 hasConcept C134018914 @default.
• W2016219982 hasConcept C173396325 @default.
• W2016219982 hasConcept C181199279 @default.
• W2016219982 hasConcept C185592680 @default.
• W2016219982 hasConcept C190283241 @default.
• W2016219982 hasConcept C2776179587 @default.
• W2016219982 hasConcept C2776329913 @default.
• W2016219982 hasConcept C2776541429 @default.
• W2016219982 hasConcept C2776990775 @default.
• W2016219982 hasConcept C2777251235 @default.
• W2016219982 hasConcept C2779982574 @default.
• W2016219982 hasConcept C2780192828 @default.
• W2016219982 hasConcept C502942594 @default.
• W2016219982 hasConcept C553450214 @default.
• W2016219982 hasConcept C55493867 @default.
• W2016219982 hasConcept C62478195 @default.
• W2016219982 hasConcept C71924100 @default.
• W2016219982 hasConcept C96232424 @default.
• W2016219982 hasConcept C98274493 @default.
• W2016219982 hasConceptScore W2016219982C121608353 @default.
• W2016219982 hasConceptScore W2016219982C126322002 @default.
• W2016219982 hasConceptScore W2016219982C134018914 @default.
• W2016219982 hasConceptScore W2016219982C173396325 @default.
• W2016219982 hasConceptScore W2016219982C181199279 @default.
• W2016219982 hasConceptScore W2016219982C185592680 @default.
• W2016219982 hasConceptScore W2016219982C190283241 @default.
• W2016219982 hasConceptScore W2016219982C2776179587 @default.
• W2016219982 hasConceptScore W2016219982C2776329913 @default.
• W2016219982 hasConceptScore W2016219982C2776541429 @default.
• W2016219982 hasConceptScore W2016219982C2776990775 @default.
• W2016219982 hasConceptScore W2016219982C2777251235 @default.
• W2016219982 hasConceptScore W2016219982C2779982574 @default.
• W2016219982 hasConceptScore W2016219982C2780192828 @default.
• W2016219982 hasConceptScore W2016219982C502942594 @default.
• W2016219982 hasConceptScore W2016219982C553450214 @default.
• W2016219982 hasConceptScore W2016219982C55493867 @default.

• next